Quasi-experimental evaluation of a nationwide diabetes prevention programme.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 19 05 2022
accepted: 17 10 2023
medline: 11 12 2023
pubmed: 16 11 2023
entrez: 15 11 2023
Statut: ppublish

Résumé

Diabetes is a leading cause of morbidity, mortality and cost of illness

Identifiants

pubmed: 37968391
doi: 10.1038/s41586-023-06756-4
pii: 10.1038/s41586-023-06756-4
doi:

Substances chimiques

Glycated Hemoglobin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-144

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Lin, X. et al. Global, regional and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci. Rep. 10, 14790 (2020).
pubmed: 32901098 pmcid: 7478957 doi: 10.1038/s41598-020-71908-9
Bommer, C. et al. The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 5, 423–430 (2017).
pubmed: 28456416 doi: 10.1016/S2213-8587(17)30097-9
Asif, M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J. Educ. Health Promot. 3, 1 (2014).
pubmed: 24741641 pmcid: 3977406 doi: 10.4103/2277-9531.127541
Taheri, S. et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 8, 477–489 (2020).
pubmed: 32445735 doi: 10.1016/S2213-8587(20)30117-0
Galaviz, K. I. et al. Interventions for reversing prediabetes: a systematic review and meta-analysis. Am. J. Prev. Med. https://doi.org/10.1016/j.amepre.2021.10.020 (2022).
Barry, E., Roberts, S., Finer, S., Vijayaraghavan, S. & Greenhalgh, T. Time to question the NHS diabetes prevention programme. Br. Med. J. https://doi.org/10.1136/bmj.h4717 (2015).
Rubio-Valera, M. et al. Barriers and facilitators for the implementation of primary prevention and health promotion activities in primary care: a synthesis through meta-ethnography. PLoS ONE 9, e89554 (2014).
pubmed: 24586867 pmcid: 3938494 doi: 10.1371/journal.pone.0089554
Hébert, E. T., Caughy, M. O. & Shuval, K. Primary care providers’ perceptions of physical activity counselling in a clinical setting: a systematic review. Br. J. Sports Med. 46, 625–631 (2012).
pubmed: 22711796 doi: 10.1136/bjsports-2011-090734
Dewhurst, A., Peters, S., Devereux-Fitzgerald, A. & Hart, J. Physicians’ views and experiences of discussing weight management within routine clinical consultations: a thematic synthesis. Patient Educ. Couns. 100, 897–908 (2017).
pubmed: 28089308 doi: 10.1016/j.pec.2016.12.017
Imbens, G. W. & Lemieux, T. Regression discontinuity designs: a guide to practice. J. Econom. 142, 615–635 (2008).
doi: 10.1016/j.jeconom.2007.05.001
Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843 (2019).
pubmed: 31518657 doi: 10.1016/j.diabres.2019.107843
Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 3, 866–875 (2015).
pmcid: 4623946 doi: 10.1016/S2213-8587(15)00291-0
Brink, S. The Diabetes Prevention Program: how the participants did it. Health Aff. 28, 57–62 (2009).
doi: 10.1377/hlthaff.28.1.57
Type 2 Diabetes: Prevention in People at High Risk (NICE, 2012); www.nice.org.uk/guidance/ph38 .
Henry, J. A. et al. Lifestyle advice for hypertension or diabetes: trend analysis from 2002 to 2017 in England. Br. J. Gen. Pract. 72, e269–e275 (2022).
pubmed: 35256386 pmcid: 8936182 doi: 10.3399/BJGP.2021.0493
Kardakis, T., Jerdén, L., Nyström, M. E., Weinehall, L. & Johansson, H. Implementation of clinical practice guidelines on lifestyle interventions in Swedish primary healthcare—a two-year follow up. BMC Health Serv. Res. 18, 227 (2018).
pubmed: 29606110 pmcid: 5880081 doi: 10.1186/s12913-018-3023-z
Milder, I. E., Blokstra, A., de Groot, J., van Dulmen, S. & Bemelmans, W. J. Lifestyle counseling in hypertension-related visits—analysis of video-taped general practice visits. BMC Fam. Pract. 9, 58 (2008).
pubmed: 18854020 pmcid: 2577675 doi: 10.1186/1471-2296-9-58
Sheppard, J. P. et al. Association of guideline and policy changes with incidence of lifestyle advice and treatment for uncomplicated mild hypertension in primary care: a longitudinal cohort study in the Clinical Practice Research Datalink. BMJ Open 8, e021827 (2018).
pubmed: 30185571 pmcid: 6129091 doi: 10.1136/bmjopen-2018-021827
Lemp, J. M. et al. Use of lifestyle interventions in primary care for individuals with newly diagnosed hypertension, hyperlipidaemia or obesity: a retrospective cohort study. J. R. Soc. Med. 115, 289–299 (2022).
pubmed: 35176215 pmcid: 9340092 doi: 10.1177/01410768221077381
Booth, H. P., Prevost, A. T. & Gulliford, M. C. Access to weight reduction interventions for overweight and obese patients in UK primary care: population-based cohort study. BMJ Open 5, e006642 (2015).
Irving, G. et al. International variations in primary care physician consultation time: a systematic review of 67 countries. BMJ Open 7, e017902 (2017).
pubmed: 29118053 pmcid: 5695512 doi: 10.1136/bmjopen-2017-017902
Keyworth, C., Epton, T., Goldthorpe, J., Calam, R. & Armitage, C. J. ‘It’s difficult, I think it’s complicated’: Health care professionals’ barriers and enablers to providing opportunistic behaviour change interventions during routine medical consultations. Br. J. Health Psychol. https://doi.org/10.1111/bjhp.12368 (2019).
Kennedy-Martin, T., Curtis, S., Faries, D., Robinson, S. & Johnston, J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 16, 495 (2015).
pubmed: 26530985 pmcid: 4632358 doi: 10.1186/s13063-015-1023-4
Ford, J. G. et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112, 228–242 (2008).
pubmed: 18008363 doi: 10.1002/cncr.23157
Rogers, J. R., Liu, C., Hripcsak, G., Cheung, Y. K. & Weng, C. Comparison of clinical characteristics between clinical trial participants and nonparticipants using electronic health record data. JAMA Netw. Open 4, e214732 (2021).
pubmed: 33825838 pmcid: 8027910 doi: 10.1001/jamanetworkopen.2021.4732
Suvarna, V. Phase IV of drug development. Perspect. Clin. Res. 1, 57–60 (2010).
pubmed: 21829783 pmcid: 3148611
Hagger, M. S. & Weed, M. DEBATE: do interventions based on behavioral theory work in the real world? Int. J. Behav. Nutr. Phys. Act. 16, 36 (2019).
pubmed: 31023328 pmcid: 6482531 doi: 10.1186/s12966-019-0795-4
Marsden, A. M. et al. ‘Finishing the race’—a cohort study of weight and blood glucose change among the first 36,000 patients in a large-scale diabetes prevention programme. Int. J. Behav. Nutr. Phys. Act. 19, 7 (2022).
pubmed: 35081984 pmcid: 8793225 doi: 10.1186/s12966-022-01249-5
Cattaneo, M. D., Idrobo, N. & Titiunik, R. A Practical Introduction to Regression Discontinuity Designs (Cambridge Univ. Press, 2019).
Valabhji, J. et al. Early outcomes from the English National Health Service Diabetes Prevention Programme. Diabetes Care 43, 152–160 (2020).
pubmed: 31719054 doi: 10.2337/dc19-1425
Bärnighausen, T. et al. Quasi-experimental study designs series—paper 7: assessing the assumptions. J. Clin. Epidemiol. 89, 53–66 (2017).
pubmed: 28365306 doi: 10.1016/j.jclinepi.2017.02.017
Selvin, E. et al. Glycated hemoglobin, diabetes and cardiovascular risk in nondiabetic adults. N. Engl. J. Med. 362, 800–811 (2010).
pubmed: 20200384 pmcid: 2872990 doi: 10.1056/NEJMoa0908359
Garg, N. et al. Hemoglobin A1c in nondiabetic patients: an independent predictor of coronary artery disease and its severity. Mayo Clin. Proc. 89, 908–916 (2014).
pubmed: 24996234 doi: 10.1016/j.mayocp.2014.03.017
Lipsitch, M., Tchetgen Tchetgen, E. & Cohen, T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 21, 383–388 (2010).
pubmed: 20335814 pmcid: 3053408 doi: 10.1097/EDE.0b013e3181d61eeb
Persson, R. et al. CPRD Aurum database: assessment of data quality and completeness of three important comorbidities. Pharmacoepidemiol. Drug Saf. 29, 1456–1464 (2020).
pubmed: 32986901 doi: 10.1002/pds.5135
Jonas, D. E. et al. Screening for prediabetes and type 2 diabetes: updated evidence report and systematic review for the US preventive services task force. JAMA 326, 744 (2021).
pubmed: 34427595 doi: 10.1001/jama.2021.10403
Pronk, N. P. Structured diet and physical activity programmes provide strong evidence of effectiveness for type 2 diabetes prevention and improvement of cardiometabolic health. Evid. Based Med. 21, 18 (2016).
Galaviz, K. I. et al. Global diabetes prevention interventions: a systematic review and network meta-analysis of the real-world impact on incidence, weight and glucose. Diabetes Care 41, 1526–1534 (2018).
pubmed: 29934481 pmcid: 6463613 doi: 10.2337/dc17-2222
Mudaliar, U. et al. Cardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysis. PLoS Med. 13, e1002095 (2016).
pubmed: 27459705 pmcid: 4961455 doi: 10.1371/journal.pmed.1002095
Cardona-Morrell, M., Rychetnik, L., Morrell, S. L., Espinel, P. T. & Bauman, A. Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis. BMC Public Health 10, 653 (2010).
pubmed: 21029469 pmcid: 2989959 doi: 10.1186/1471-2458-10-653
Diabetes Prevention Programme: Non-Diabetic Hyperglycaemia, January to December 2021. National Diabetes Audit (NHS Digital, 2022); https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/dpp-q3-21-22-data .
Whelan, M. & Bell, L. The English National Health Service Diabetes Prevention Programme (NHS DPP): a scoping review of existing evidence. Diabet. Med. 39, e14855 (2022).
pubmed: 35441747 pmcid: 9321029 doi: 10.1111/dme.14855
Calderón-Larrañaga, S. et al. Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation. BMC Med. 21, 91 (2023).
pubmed: 36907857 pmcid: 10008720 doi: 10.1186/s12916-023-02796-9
Poupakis, S., Kolotourou, M., MacMillan, H. J. & Chadwick, P. M. Attendance, weight loss and participation in a behavioural diabetes prevention programme. Int. J. Behav. Med. https://doi.org/10.1007/s12529-022-10146-x (2023).
Katzke, V. A., Kaaks, R. & Kühn, T. Lifestyle and cancer risk. Cancer J. 21, 104–110 (2015).
pubmed: 25815850 doi: 10.1097/PPO.0000000000000101
Silverio, A. et al. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients. BMC Cardiovasc. Disord. 21, 23 (2021).
pubmed: 33413093 pmcid: 7789083 doi: 10.1186/s12872-020-01816-3
Hawkes, R. E., Cameron, E., Cotterill, S., Bower, P. & French, D. P. The NHS Diabetes Prevention Programme: an observational study of service delivery and patient experience. BMC Health Serv. Res. 20, 1098 (2020).
pubmed: 33246460 pmcid: 7694420 doi: 10.1186/s12913-020-05951-7
Penn, L. et al. NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation. BMJ Open 8, e019467 (2018).
pubmed: 29467134 pmcid: 5855311 doi: 10.1136/bmjopen-2017-019467
Diabetes Prevention Programme. NHS https://gps.northcentrallondon.icb.nhs.uk/service/diabetes-prevention-programme-dpp (2023).
McManus, E., Meacock, R., Parkinson, B. & Sutton, M. Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: an observational study. Lancet Reg. Health Eur. 19, 100420 (2022).
pubmed: 35664052 pmcid: 9160476 doi: 10.1016/j.lanepe.2022.100420
National Diabetes Audit. Audit, survey, other reports and statistics. NHS Digital https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit (2018).
Wolf, A. et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int. J. Epidemiol. 48, 1740–1740g (2019).
pubmed: 30859197 pmcid: 6929522 doi: 10.1093/ije/dyz034
Herbert, A., Wijlaars, L., Zylbersztejn, A., Cromwell, D. & Hardelid, P. Data resource profile: Hospital Episode Statistics Admitted Patient Care (HES APC). Int. J. Epidemiol. 46, 1093–1093i (2017).
pubmed: 28338941 pmcid: 5837677 doi: 10.1093/ije/dyx015
Sammon, C. J., Leahy, T. P. & Ramagopalan, S. Nonindependence of patient data in the clinical practice research datalink: a case study in atrial fibrillation patients. J. Comp. Eff. Res. 9, 395–403 (2020).
pubmed: 32056446 doi: 10.2217/cer-2019-0191
Hernán, M. A. Methods of public health research—strengthening causal inference from observational data. N. Engl. J. Med. 385, 1345–1348 (2021).
pubmed: 34596980 doi: 10.1056/NEJMp2113319
Hernán, M. A. & Robins, J. M. Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758–764 (2016).
pubmed: 26994063 pmcid: 4832051 doi: 10.1093/aje/kwv254
Non-Diabetic Hyperglycaemia, 2019-20 (NHS Digital, 2021); https://files.digital.nhs.uk/31/C59C4B/NDA_NDH_MainReport_2019-20_V1.pdf .
Davidson, J. Clinical codelist—HES—Major Adverse Cardiovascular Event. London School of Hygiene & Tropical Medicine https://doi.org/10.17037/DATA.00002198 (2021).
Imbens, G. & Kalyanaraman, K. Optimal bandwidth choice for the regression discontinuity estimator. Rev. Econ. Stud. 79, 933–959 (2012).
doi: 10.1093/restud/rdr043
Calonico, S., Cattaneo, M. D. & Titiunik, R. Robust nonparametric vonfidence intervals for regression-discontinuity designs: robust nonparametric confidence intervals. Econometrica 82, 2295–2326 (2014).
doi: 10.3982/ECTA11757
Calonico, S., Cattaneo, M. D., Farrell, M. H. & Titiunik, R. Regression discontinuity designs using covariates. Rev. Econ. Stat. 101, 442–451 (2019).
doi: 10.1162/rest_a_00760
R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2022).
Calonico, S., Cattaneo, M. D., Farrell, M. H. & Titiunik, R. rdrobust: robust data-driven statistical inference in regression-discontinuity designs. R package v.2.1.0 (2022).
Callaway, B. & Sant’Anna, P. H. C. Difference-in-differences with multiple time periods. J. Econ. 225, 200–230 (2021).
doi: 10.1016/j.jeconom.2020.12.001
Callaway, B. & Sant’Anna, P. did: Difference in Differences. R package v.2.1.2 (2022).
Proposed CCG Configuration and Member Practices Published. NHS England www.england.nhs.uk/2012/05/ccg-configuration/ (2012).
Output Area to Primary Care Organisation to Strategic Health Authority (December 2011) Lookup in England and Wales. ONS Geography Office of National Statistics https://geoportal.statistics.gov.uk/datasets/ons::output-area-to-primary-care-organisation-to-strategic-health-authority-december-2011-lookup-in-england-and-wales-1/about (2018).
Lower Layer Super Output Area (2011) to Clinical Commissioning Group to Local Authority District (April 2021) Lookup in England. ONS Geography Office of National Statistics https://geoportal.statistics.gov.uk/datasets/ons::lower-layer-super-output-area-2011-to-clinical-commissioning-group-to-local-authority-district-april-2021-lookup-in-england-1/about (2021).
Gaure, S. lfe: linear group fixed effects. R package v.2.8-8 (2022).
Ho, D. E., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Softw. 42, 1–28 (2011).
Snowden, J. M., Rose, S. & Mortimer, K. M. Implementation of G-computation on a simulated data set: demonstration of a causal inference technique. Am. J. Epidemiol. 173, 731–738 (2011).
pubmed: 21415029 pmcid: 3105284 doi: 10.1093/aje/kwq472
Greifer, N. & Stuart, E. A. Choosing the causal estimand for propensity score analysis of observational studies. Preprint at https://doi.org/10.48550/ARXIV.2106.10577 (2021).
Chatton, A. et al. G-computation, propensity score-based methods and targeted maximum likelihood estimator for causal inference with different covariates sets: a comparative simulation study. Sci. Rep. 10, 9219 (2020).
pubmed: 32514028 pmcid: 7280276 doi: 10.1038/s41598-020-65917-x
Arel-Bundock, V. marginaleffects: marginal effects, marginal means, predictions and contrasts. R package v.0.7.1 (2022).

Auteurs

Julia M Lemp (JM)

Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany.
Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA, USA.

Christian Bommer (C)

Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany.
Department of Economics and Centre for Modern Indian Studies, University of Goettingen, Göttingen, Germany.

Min Xie (M)

Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany.
Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA, USA.

Felix Michalik (F)

Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany.
Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA, USA.

Anant Jani (A)

Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany.
University of Oxford, Oxford, UK.

Justine I Davies (JI)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Centre for Global Surgery, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Till Bärnighausen (T)

Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany.
Africa Health Research Institute, Somkhele, South Africa.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.

Sebastian Vollmer (S)

Department of Economics and Centre for Modern Indian Studies, University of Goettingen, Göttingen, Germany.

Pascal Geldsetzer (P)

Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA, USA. pgeldsetzer@stanford.edu.
Department of Epidemiology and Population Health, Stanford University, Stanford, CA, USA. pgeldsetzer@stanford.edu.
Chan Zuckerberg Biohub-San Francisco, San Francisco, CA, USA. pgeldsetzer@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH